In prostate cancer, GFRa1 plays a limiting role that supports GDNF/RET signaling to activate both the PI3K/AKT and MAPK/ERK pathways through phosphorylation of RET on Tyr1062, enhancing proliferation in vitro and tumor growth in vivo1, 49. This evidence concerns the gene GFRA1 and prostate carcinoma.